Evolution of the Average Target: Silence Therapeutics plc

Evolution of the Average Target - Silence Therapeutics plc

Evolution of the Target Price: Silence Therapeutics plc

Evolution of the Target Price - Silence Therapeutics plc

Changes in Analyst Recommendations: Silence Therapeutics plc

5cd6732d24d58aa257936c.dUwrnAaM2B83203hwmfbbAMitvTMlJFYuqu6hoPh-kM.OzRgqze9sEADjHXMl1KdAzIW9JiU39Z12eD2suqVsHAQGmL1fKGdR1m-Jg~14d60471231919b2f250fc29eff5398c

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
Average
Weighted average by Cap.


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
19.75USD
Average target price
19.75USD
Spread / Average Target
-.--%
High Price Target
20.00USD
Spread / Highest target
+1.27%
Low Price Target
19.00USD
Spread / Lowest Target
-3.80%

Analyst Consensus Detail

Analyst consensus - Silence Therapeutics plc

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Silence Therapeutics plc
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Silence Therapeutics plc
  1. Stock Market
  2. Stocks
  3. SLN Stock
  4. SLNCF Stock
  5. Consensus Silence Therapeutics plc